Spatial OMICS Market by Technology (Genomics, Proteomics, Transcriptomics), Sample Type (FFPE, Fresh Frozen), Product, Workflow, End-use - Global Forecast 2024-2030

Spatial OMICS Market by Technology (Genomics, Proteomics, Transcriptomics), Sample Type (FFPE, Fresh Frozen), Product, Workflow, End-use - Global Forecast 2024-2030


The Spatial OMICS Market size was estimated at USD 521.18 million in 2023 and expected to reach USD 586.66 million in 2024, at a CAGR 13.14% to reach USD 1,237.48 million by 2030.

Spatial omics encompasses advanced techniques and technologies for analyzing the spatial organization of biological molecules within cells, tissues, and organisms. This sector serves various industries, including pharmaceuticals, biotechnology, academic research, and diagnostics. Factors such as the rising prevalence of complex diseases like cancer, along with the advancements in next-generation sequencing (NGS) and government funding for life science research initiatives, have increased the application areas of spatial omics. However, high costs associated with implementing advanced imaging tools, along with data standardization and interoperability concerns, may impede market growth. However, booming technologies such as artificial intelligence (AI) and machine learning (ML) hold the potential to revolutionize data analysis in spatial omics studies. Furthermore, the development of integrated multi-omics platforms that combine transcriptomics, proteomics, metabolomics, and genomics, leveraging cloud computing technology, is expected to provide growth prospects for the market.

Regional Insights

The global spatial OMICS market is experiencing significant growth across the Americas region owing to significant investment led in research and development across regions such as the United States & Canada, supported by the presence of biotechnology & research companies along with academic institutions. In Europe, countries like Sweden and Germany lead investments in spatial OMICS technologies through EU-funded projects like Horizon 2020. Research institutes such as The European Bioinformatics Institute(EMBL) and Wellcome Sanger Institute contribute significantly to advancing this field. Increasing focus on precision medicine and genomic research in the Middle East region opens up opportunities for adopting spatial OMIC technologies in clinical decision-making. Moreover, the Asia Pacific region holds the growth potential for the spatial OMICS, considering the growing biotechnology sectors and increased government funding for scientific research across major economies such as China & India. India is gradually adopting spatial OMIC technology through substantial investments by its Department of Biotechnology (DBT), potentially paving the way for partnerships between researchers and industry players interested in these innovative applications.

Market Insights
  • Market Dynamics

    The market dynamics represent an ever-changing landscape of the Spatial OMICS Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
    • Market Drivers
      • Rapid Advances in the Sequencing of Tissues, Genes, and Single Cell
      • Rise in Government Support for Genomics and Sequencing Technologies
      • Increasing Demand for Personalized Medicine
      • Market Restraints
        • Slow Implementation of Technology
        • Market Opportunities
          • Gradual Development of Novel Technologies for Spatial OMICS
          • Rising Focusing on New Approaches for Increasing the Application of FFPE in Spatial Transcriptomic Studies Owing to Presence of Substantial Research Organizations
          • Market Challenges
            • Challenges Pertaining to the Single-Cell Transcriptomics
            • Market Segmentation Analysis
              • Product: Penetration of mass spectrometry for spatial distribution of different molecules from tissue
              • End-use: Significant application of spatial OMICS technologies by Academic & translational research institutes for cellular mechanisms studies
              • Market Disruption Analysis
              • Porter’s Five Forces Analysis
              • Value Chain & Critical Path Analysis
              • Pricing Analysis
              • Technology Analysis
              • Patent Analysis
              • Trade Analysis
              • Regulatory Framework Analysis
              FPNV Positioning Matrix

              The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Spatial OMICS Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

              Market Share Analysis

              The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Spatial OMICS Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

              Recent Developments
              • OMAPiX Announces Strategic Partnerships with Spatial Biology Platform Providers to Accelerate Life Science Research and Drug Development

                OMAPiX has announced partnerships with spatial biology platform provider Vizgen, Inc. These partnerships aim to accelerate life science research and drug development by granting access to the latest bioimaging technologies and applications. Through these partnerships, life-science researchers will have improved capabilities in collecting, analyzing, and visualizing complex spatial data from biological samples.

                Owkin Invests USD 50m In Spatial Omics Project That Revolutionizes Cancer Research

                Owkin, Inc., has invested a substantial USD 50 million in the Project Revolutionizing Cancer Research to develop a spatial OMICS system. The primary objective of this project is to analyze multiple cancer datasets by leveraging artificial intelligence and machine learning , thereby establishing a comprehensive understanding of the fundamental spatio-temporal relationships in cancer biology. This investment reflects Owkin's dedication to transforming cancer diagnosis and treatment through AI-driven research.

                Bio-Techne And Lunaphore Establish Strategic Partnership To Develop The First Fully Automated Same-Slide Spatial Multiomics Solution

                Bio-Techne Corporation and Lunaphore Technologies S.A. have partnered to create a groundbreaking spatial multiomics solution. This innovative solution, which will operate on the same slides, aims to enhance biological research's speed, accuracy, and sensitivity. This partnership effort will pave the way for new advancements in the field, driving scientific progress and unlocking new possibilities for the future.
              Strategy Analysis & Recommendation

              The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Spatial OMICS Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

              Key Company Profiles

              The report delves into recent significant developments in the Spatial OMICS Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., Akoya Biosciences, Inc., Bio-Techne Corporation, Biognosys AG, BioSpyder Technologies Inc., Brooks Automation, Inc., Bruker Corporation, Danaher Corporation, Dovetail Genomics, LLC by Cantata Bio, LLC, Hologic, Inc., IonPath, Inc., Lunaphore Technologies S.A., Molecular Machines & Industries GmbH, NanoString Technologies, Inc., PerkinElmer, Inc., RareCyte, Inc., Rebus Biosystems, Inc., Resolve BioSciences GmbH, S2 Genomics, Inc., Seven Bridges Genomics Inc, Standard BioTools Inc., Ultivue, Inc., Veranome Biosystems, LLC by Applied Materials, Inc., and Vizgen, Inc..

              Market Segmentation & Coverage

              This research report categorizes the Spatial OMICS Market to forecast the revenues and analyze trends in each of the following sub-markets:
              • Technology
                • Genomics
                • Proteomics
                • Transcriptomics
                • Sample Type
                  • FFPE
                  • Fresh Frozen
                  • Product
                    • Consumables
                    • Instruments
                      • Flow Cytometry
                      • IHC
                      • Mass Spectrometry
                      • Microscopy
                      • Sequencing Platforms
                      • Software
                        • Bioinformatics Tools
                        • Imaging Tools
                        • Storage & Management Databases
                        • Workflow
                          • Data Analysis
                          • Instrumental Analysis
                          • Sample Preparation
                          • End-use
                            • Academic & Translational Research Institutes
                            • Pharmaceutical and Biotechnology Companies
                            • Region
                              • Americas
                                • Argentina
                                • Brazil
                                • Canada
                                • Mexico
                                • United States
                                  • California
                                  • Florida
                                  • Illinois
                                  • New York
                                  • Ohio
                                  • Pennsylvania
                                  • Texas
                                  • Asia-Pacific
                                    • Australia
                                    • China
                                    • India
                                    • Indonesia
                                    • Japan
                                    • Malaysia
                                    • Philippines
                                    • Singapore
                                    • South Korea
                                    • Taiwan
                                    • Thailand
                                    • Vietnam
                                    • Europe, Middle East & Africa
                                      • Denmark
                                      • Egypt
                                      • Finland
                                      • France
                                      • Germany
                                      • Israel
                                      • Italy
                                      • Netherlands
                                      • Nigeria
                                      • Norway
                                      • Poland
                                      • Qatar
                                      • Russia
                                      • Saudi Arabia
                                      • South Africa
                                      • Spain
                                      • Sweden
                                      • Switzerland
                                      • Turkey
                                      • United Arab Emirates
                                      • United Kingdom


                                      Please Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rapid Advances in the Sequencing of Tissues, Genes, and Single Cell
5.1.1.2. Rise in Government Support for Genomics and Sequencing Technologies
5.1.1.3. Increasing Demand for Personalized Medicine
5.1.2. Restraints
5.1.2.1. Slow Implementation of Technology
5.1.3. Opportunities
5.1.3.1. Gradual Development of Novel Technologies for Spatial OMICS
5.1.3.2. Rising Focusing on New Approaches for Increasing the Application of FFPE in Spatial Transcriptomic Studies Owing to Presence of Substantial Research Organizations
5.1.4. Challenges
5.1.4.1. Challenges Pertaining to the Single-Cell Transcriptomics
5.2. Market Segmentation Analysis
5.2.1. Product: Penetration of mass spectrometry for spatial distribution of different molecules from tissue
5.2.2. End-use: Significant application of spatial OMICS technologies by Academic & translational research institutes for cellular mechanisms studies
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework Analysis
5.8. Client Customization
6. Spatial OMICS Market, by Technology
6.1. Introduction
6.2. Genomics
6.3. Proteomics
6.4. Transcriptomics
7. Spatial OMICS Market, by Sample Type
7.1. Introduction
7.2. FFPE
7.3. Fresh Frozen
8. Spatial OMICS Market, by Product
8.1. Introduction
8.2. Consumables
8.3. Instruments
8.4. Software
9. Spatial OMICS Market, by Workflow
9.1. Introduction
9.2. Data Analysis
9.3. Instrumental Analysis
9.4. Sample Preparation
10. Spatial OMICS Market, by End-use
10.1. Introduction
10.2. Academic & Translational Research Institutes
10.3. Pharmaceutical and Biotechnology Companies
11. Americas Spatial OMICS Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Spatial OMICS Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Spatial OMICS Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.3.1. OMAPiX Announces Strategic Partnerships with Spatial Biology Platform Providers to Accelerate Life Science Research and Drug Development
14.3.2. Owkin Invests USD 50m In Spatial Omics Project That Revolutionizes Cancer Research
14.3.3. Bio-Techne And Lunaphore Establish Strategic Partnership To Develop The First Fully Automated Same-Slide Spatial Multiomics Solution
15. Competitive Portfolio
15.1. Key Company Profiles
15.2. Key Product Portfolio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings